Search hospitals > South Carolina > Charleston

Roper Hospital

Claim this profile
Charleston, South Carolina 29401
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Breast cancer
Conducts research for Pancreatic Cancer
Conducts research for Non-Small Cell Lung Cancer
83 reported clinical trials
10 medical researchers
Photo of Roper Hospital in CharlestonPhoto of Roper Hospital in CharlestonPhoto of Roper Hospital in Charleston

Summary

Roper Hospital is a medical facility located in Charleston, South Carolina. This center is recognized for care of Breast Cancer, Lung Cancer, Breast cancer, Pancreatic Cancer, Non-Small Cell Lung Cancer and other specialties. Roper Hospital is involved with conducting 83 clinical trials across 167 conditions. There are 10 research doctors associated with this hospital, such as Michael Field, M.D., Jacobo Mintzer, MD, David Ellison, and Daniel D. Kirchoff.

Area of expertise

1Breast Cancer
Global Leader
Roper Hospital has run 20 trials for Breast Cancer. Some of their research focus areas include:
ER positive
HER2 negative
PR positive
2Lung Cancer
Global Leader
Roper Hospital has run 16 trials for Lung Cancer. Some of their research focus areas include:
Stage II
Stage I
Stage III

Top PIs

Clinical Trials running at Roper Hospital

Lung Cancer
Pancreatic Cancer
Pancreatic Carcinoma
ALK Gene Rearrangement
Gliosarcoma
Glioblastoma
Breast Cancer
Breast cancer
Non-Small Cell Lung Cancer
Cancer
Image of trial facility.

Crizotinib

for Non-Small Cell Lung Cancer

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Image of trial facility.

Immunotherapy + Chemotherapy

for Non-Small Cell Lung Cancer

This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Roper Hospital?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security